These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25209879)

  • 1. Initial serum ferritin predicts number of therapeutic phlebotomies to iron depletion in secondary iron overload.
    Panch SR; Yau YY; West K; Diggs K; Sweigart T; Leitman SF
    Transfusion; 2015 Mar; 55(3):611-22. PubMed ID: 25209879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of phlebotomy to reduce transfusional iron overload in adult, long-term survivors of acute leukemia.
    Franchini M; Gandini G; Veneri D; de Matteis G; Federici F; Solero P; Aprili G
    Transfusion; 2004 Jun; 44(6):833-7. PubMed ID: 15157247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rusfertide for the treatment of iron overload in HFE-related haemochromatosis: an open-label, multicentre, proof-of-concept phase 2 trial.
    Kowdley KV; Modi NB; Peltekian K; Vierling JM; Ferris C; Valone FH; Gupta S
    Lancet Gastroenterol Hepatol; 2023 Dec; 8(12):1118-1128. PubMed ID: 37863080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
    Busca A; Falda M; Manzini P; D'Antico S; Valfrè A; Locatelli F; Calabrese R; Chiappella A; D'Ardia S; Longo F; Piga A
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phlebotomy to reduce iron overload in patients cured of thalassemia by bone marrow transplantation. Italian Cooperative Group for Phlebotomy Treatment of Transplanted Thalassemia Patients.
    Angelucci E; Muretto P; Lucarelli G; Ripalti M; Baronciani D; Erer B; Galimberti M; Giardini C; Gaziev D; Polchi P
    Blood; 1997 Aug; 90(3):994-8. PubMed ID: 9242528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Laboratory Associations with Persistent Hyperferritinemia in 373 Black Hemochromatosis and Iron Overload Screening Study Participants.
    Barton JC; Barton JC; Adams PC
    Ann Hepatol; 2017; 16(5):802-811. PubMed ID: 28809726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of iron overload management in allogeneic hematopoietic cell transplantation survivors.
    Majhail NS; Lazarus HM; Burns LJ
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):832-7. PubMed ID: 20079863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Kamble RT; Selby GB; Mims M; Kharfan-Dabaja MA; Ozer H; George JN
    Biol Blood Marrow Transplant; 2006 May; 12(5):506-10. PubMed ID: 16635785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generalized pruritus in dysmetabolic hyperferritinemia treated by phlebotomy.
    Brigant F; Hautefeuille V; Dadban A; Lok C; Nguyen-Khac E; Chaby G
    Dermatol Online J; 2015 Sep; 21(9):. PubMed ID: 26437295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of blood letting on serum aminotransferase levels of patients with chronic hepatitis C and iron overload.
    Girelli CM; Mirata C; Casiraghi A
    Recenti Prog Med; 1998 May; 89(5):241-4. PubMed ID: 9676130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An assessment of iron overload in children treated for cancer and nonmalignant hematologic disorders.
    Rascon J; Rageliene L; Stankeviciene S; Palionis D; Tamosiunas AE; Valeviciene N; Zvirblis T
    Eur J Pediatr; 2014 Sep; 173(9):1137-46. PubMed ID: 24659311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison between phlebotomy and erythrocytapheresis of iron overload in patients with HFE gene mutations].
    Fernández-Mosteirín N; Salvador-Osuna C; García-Erce JA; Orna E; Pérez-Lungmus G; Giralt M
    Med Clin (Barc); 2006 Sep; 127(11):409-12. PubMed ID: 17020684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron overload in hematopoietic cell transplantation.
    Majhail NS; Lazarus HM; Burns LJ
    Bone Marrow Transplant; 2008 Jun; 41(12):997-1003. PubMed ID: 18438425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperferritinemia after adult allogeneic hematopoietic cell transplantation: quantification of iron burden by determining non-transferrin-bound iron.
    Goto T; Ikuta K; Inamoto Y; Kamoshita S; Yokohata E; Koyama D; Onodera K; Seto A; Watanabe K; Imahashi N; Tsukamoto S; Ozawa Y; Sasaki K; Ito M; Kohgo Y; Miyamura K
    Int J Hematol; 2013 Jan; 97(1):125-34. PubMed ID: 23264147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic phlebotomy is safe in children with sickle cell anaemia and can be effective treatment for transfusional iron overload.
    Aygun B; Mortier NA; Kesler K; Lockhart A; Schultz WH; Cohen AR; Alvarez O; Rogers ZR; Kwiatkowski JL; Miller ST; Sylvestre P; Iyer R; Lane PA; Ware RE;
    Br J Haematol; 2015 Apr; 169(2):262-6. PubMed ID: 25612463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of phlebotomy on lipid metabolism in subjects with hereditary hemochromatosis.
    Casanova-Esteban P; Guiral N; Andrés E; Gonzalvo C; Mateo-Gallego R; Giraldo P; Paramo JA; Civeira F
    Metabolism; 2011 Jun; 60(6):830-4. PubMed ID: 20846699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year results from a prospective randomized trial comparing phlebotomy with deferasirox for the treatment of iron overload in pediatric patients with thalassemia major following curative stem cell transplantation.
    Inati A; Kahale M; Sbeiti N; Cappellini MD; Taher AT; Koussa S; Nasr TA; Musallam KM; Abbas HA; Porter JB
    Pediatr Blood Cancer; 2017 Jan; 64(1):188-196. PubMed ID: 27576370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient compliance with phlebotomy therapy for iron overload associated with hemochromatosis.
    Hicken BL; Tucker DC; Barton JC
    Am J Gastroenterol; 2003 Sep; 98(9):2072-7. PubMed ID: 14499790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic and hepatic effects of bloodletting in dysmetabolic iron overload syndrome: A randomized controlled study in 274 patients.
    Lainé F; Ruivard M; Loustaud-Ratti V; Bonnet F; Calès P; Bardou-Jacquet E; Sacher-Huvelin S; Causse X; Beusnel C; Renault A; Bellissant E; Deugnier Y;
    Hepatology; 2017 Feb; 65(2):465-474. PubMed ID: 27685251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of repeated phlebotomies in hypertriglyceridemia and iron overload: A prospective, randomized, controlled trial.
    Mateo-Gallego R; Lacalle L; Pérez-Calahorra S; Marco-Benedí V; Recasens V; Padrón N; Lamiquiz-Moneo I; Baila-Rueda L; Jarauta E; Calmarza P; Cenarro A; Civeira F
    J Clin Lipidol; 2018; 12(5):1190-1198. PubMed ID: 30049591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.